Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc
- PMID: 12083774
- DOI: 10.1016/s0006-291x(02)00636-8
Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc
Abstract
Zinc is an important trace element found in most body tissues as bivalent cations and has essential roles in human health. The insulin-like effect of zinc cations raises the possibility that they inhibit glycogen synthase kinase-3beta (GSK-3beta), a serine/threonine protein kinase linked with insulin resistance and type 2 diabetes. Here we show that physiological concentrations of zinc ions directly inhibit GSK-3beta in vitro in an uncompetitive manner. Treatment of HEK-293 cells with zinc enhanced glycogen synthase activity and increased the intracellular levels of beta-catenin, providing evidence for inhibition of endogenous GSK-3beta by zinc. Moreover, zinc ions enhanced glucose uptake 3-fold in isolated mouse adipocytes, an increase similar to activation with saturated concentrations of insulin. We propose that the in vivo insulin-mimetic actions of zinc are mediated via direct inhibition of endogenous GSK-3beta.
(c) 2002 Elsevier Science (USA).
Similar articles
-
Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.Diabetes. 2002 Jul;51(7):2190-8. doi: 10.2337/diabetes.51.7.2190. Diabetes. 2002. PMID: 12086949
-
Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):163-81. doi: 10.1042/bj3360163. Biochem J. 1998. PMID: 9806898 Free PMC article.
-
Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes.J Biol Chem. 2000 May 26;275(21):15765-72. doi: 10.1074/jbc.M910002199. J Biol Chem. 2000. PMID: 10748179
-
Glycogen synthase kinase 3: an emerging therapeutic target.Trends Mol Med. 2002 Mar;8(3):126-32. doi: 10.1016/s1471-4914(01)02266-3. Trends Mol Med. 2002. PMID: 11879773 Review.
-
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.Med Res Rev. 2002 Jul;22(4):373-84. doi: 10.1002/med.10011. Med Res Rev. 2002. PMID: 12111750 Review.
Cited by
-
Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity.Neural Plast. 2017;2017:3682752. doi: 10.1155/2017/3682752. Epub 2017 Feb 19. Neural Plast. 2017. PMID: 28299207 Free PMC article. Review.
-
Dietary zinc reduction, pyruvate supplementation, or zinc transporter 5 knockout attenuates β-cell death in nonobese diabetic mice, islets, and insulinoma cells.J Nutr. 2012 Dec;142(12):2119-27. doi: 10.3945/jn.112.167031. Epub 2012 Oct 24. J Nutr. 2012. PMID: 23096014 Free PMC article.
-
Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.Mol Neurobiol. 2005 Oct;32(2):173-202. doi: 10.1385/MN:32:2:173. Mol Neurobiol. 2005. PMID: 16215281 Review.
-
Binding Zinc and Oxo-Vanadium Insulin-Mimetic Complexes to Phosphatase Enzymes: Structure, Electronics and Implications.Molecules. 2025 Mar 26;30(7):1469. doi: 10.3390/molecules30071469. Molecules. 2025. PMID: 40286074 Free PMC article.
-
A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).Biochem J. 2013 Oct 15;455(2):229-37. doi: 10.1042/BJ20130483. Biochem J. 2013. PMID: 23919497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous